Business
Scientific research for plant cultivation with George Hodgin CEO of Biopharmaceutical Research Company. Our next guest is a graduate of the Stanford Graduate School of Business, a former Navy SEAL Officer and the CEO of Biopharmaceutical Research Company. This past August, the federal government announced it would begin processing dozens of pending applications for permission to cultivate the plant for scientific research. The U.S. Drug Enforcement Administration's decision comes after several years of delay for some applicants and a lawsuit filed against the agency by one cannabis researcher.